David J. Mazzo, Chief Executive Officer at Caladrius Biosciences, Inc. (CLBS), bought 20,000 shares at $1.40 ($28K) on 2015-08-17, disclosed to the SEC on 2015-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.